Status:
COMPLETED
A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)
Lead Sponsor:
Xention Ltd
Conditions:
Elevated Lp(a)
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
A study in males and females with elevated Lp(a) to look at the effects of TA-8995 on Lp(a) levels.
Eligibility Criteria
Inclusion
- Male and female (of non-child bearing potential) subjects with elevated Lp(a) levels
Exclusion
- Clinically significant medical history
- Abnormal laboratory results (other than lipid levels) or vital signs
- Receiving any other drug therapy
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT02241772
Start Date
September 1 2014
End Date
February 1 2015
Last Update
February 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital
Herlev, Denmark, DK-2730